- Home
- HWH vs PTHL Comparison
HWH vs PTHL Comparison
Compare HWH & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWH
- PTHL
- Stock Information
- Founded
- HWH 2021
- PTHL 1998
- Country
- HWH United States
- PTHL China
- Employees
- HWH N/A
- PTHL N/A
- Industry
- HWH Other Pharmaceuticals
- PTHL
- Sector
- HWH Health Care
- PTHL
- Exchange
- HWH Nasdaq
- PTHL Nasdaq
- Market Cap
- HWH 10.1M
- PTHL 8.8M
- IPO Year
- HWH N/A
- PTHL 2024
- Fundamental
- Price
- HWH $1.77
- PTHL $0.60
- Analyst Decision
- HWH
- PTHL
- Analyst Count
- HWH 0
- PTHL 0
- Target Price
- HWH N/A
- PTHL N/A
- AVG Volume (30 Days)
- HWH 24.0K
- PTHL 122.7K
- Earning Date
- HWH 10-22-2025
- PTHL 01-01-0001
- Dividend Yield
- HWH N/A
- PTHL N/A
- EPS Growth
- HWH N/A
- PTHL N/A
- EPS
- HWH N/A
- PTHL N/A
- Revenue
- HWH $1,099,428.00
- PTHL $448,196.00
- Revenue This Year
- HWH N/A
- PTHL N/A
- Revenue Next Year
- HWH N/A
- PTHL N/A
- P/E Ratio
- HWH N/A
- PTHL N/A
- Revenue Growth
- HWH N/A
- PTHL N/A
- 52 Week Low
- HWH $0.90
- PTHL $0.47
- 52 Week High
- HWH $7.77
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- HWH 30.79
- PTHL 36.00
- Support Level
- HWH $1.75
- PTHL $0.47
- Resistance Level
- HWH $1.85
- PTHL $0.65
- Average True Range (ATR)
- HWH 0.10
- PTHL 0.06
- MACD
- HWH -0.02
- PTHL 0.04
- Stochastic Oscillator
- HWH 5.50
- PTHL 63.46
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.